Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "BioMedix Vascular Solutions" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about BioMedix Vascular Solutions for you to read. Along with our medical data and news we also list BioMedix Vascular Solutions Clinical Trials, which are updated daily. BioPortfolio also has a large database of BioMedix Vascular Solutions Companies for you to search.
Teleflex unit Vascular Solutions' OptiSphere embolization spheres were released by Medtronic for embolization of hypervascula -More-
(SAGE) Vascular disease is a leading cause of morbidity and death worldwide. In order to combat the disease, specialists must have skills with imaging techniques. With this in mind, Vascular Medicine, the official journal of the Society for Vascular Medicine, dedicated its April 2018 issue to the topic of vascular imaging and diagnostics.
Helix BioMedix Inc Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.This uptotheminute company report will help you to formulate strategies to drive your business ...
Bluegrass Vascular Technologies (Bluegrass Vascular), a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, has successfully completed enrollment
Increasing evidence suggests that cerebral vascular dysfunction is associated with the early stages of Alzheimer’s disease (AD). Vascular endothelial growth factor (VEGF) is one of the key players involved in ...
In what appears to be its second financing, Access Vascular Inc. raised $1.9mm from seven undisclosed investors. The company ...
Intact Vascular Inc. (devices for minimally invasive peripheral vascular procedures) raised $20mm in its Series C financing t...
Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, announced that its Tack Optimized Balloon Angioplasty III (TOBA III) clinical trial has
A two-tranche Series C financing round pulled in $20 million for Wayne, Pa.-based Intact Vascular, which makes the Tack endov -More-
A better understanding of the contribution of vascular calcification to cardiovascular mortality in CKD could have important therapeutic implications. Nephrology Dialysis Transplantation
LeMaitre Vascular Inc. is paying $14.2mm--$11mm up front and $3.2mm in two later installments ($2mm in 12 months and $1.2m in...
Newly approved GLOW800 provides surgeons with a 'complete view of anatomy and physiology during vascular neurosurgery, the company says. FDA Approvals
LeMaitre Vascular has acquired Applied Medical Resources' vascular clot business for $11 million in cash plus more than $3 mi -More-
Corindus Vascular Robotics has promoted Douglas Teany from senior vice president of research and development and operations t -More-
Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that data from its Tack Optimized Balloon Angioplasty II pivotal clinical trial will be presented at the 15th Annual VIVA Conference in Las Vegas, NV on November 5-8.
A round of financing has brought in $3.4 million for Access Vascular. -More-
Data from a study presented at the Society for Vascular Surgery Vascular Annual Meeting showed transcarotid artery revascular -More-
(RUDN University) A team of scientists from the Medical Institute of RUDN University compared two factors of vascular ageing -- CF-PWV and CAVI. Both of these parameters determine the main indicator of vascular ageing -- arterial stiffness -- with high precision. However, they are influenced by age and certain metabolism abnormalities in different ways. The study is expected to help cardiologists ...
Douglas Teany has taken on a new role at Corindus Vascular Robotics (NYSE American: CVRS) as the Waltham, MA, company’s chief operating officer. Since 2016, he had served as Corindus’ senior vice president of R&D and operations. Corindus has commercialized the CorPath System, an FDA-cleared medical device that uses robotics technology in vascular procedures.
A round of financing involving 29 investors has brought in $12.4 million for Cresskill, N.J.-based Vascular Therapies, bringi -More-
A round of equity financing involving seven unnamed investors has brought in $1.9 million for Access Vascular, an SEC filing -More-
A 300-patient pivotal trial has been launched by Vascular Dynamics to evaluate the use of its MobiusHD device in patients wit -More-
A mixed round of financing involving three anonymous sources pulled in $10 million for Intact Vascular, an SEC filing showed. -More-
Corindus Vascular Robotics has announced the completion of a deal with Cowen for an at-the-market offering of its common stoc -More-
Japan's Pharmaceuticals and Medical Devices Agency has granted Corindus Vascular Robotics clearance to market its CorPath GRX -More-